Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)

Ligand Pharmaceuticals Revenue

Alexandria Co. For Pharmaceuticals & Chemical Industries had revenue of 780.08M EGP in the quarter ending December 31, 2024, with 60.35% growth. This brings the company's revenue in the last twelve months to 2.31B, up 27.83% year-over-year. In the fiscal year ending June 30, 2024, Alexandria Co. For Pharmaceuticals & Chemical Industries had annual revenue of 1.77B with 19.12% growth.

• Revenue (ttm): 2.31B
• Revenue Growth: +27.83%
• P/S Ratio: 1.24
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 2.86B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	1.77B	283.76M	19.12%
Jun 30, 2023	1.48B	384.31M	34.94%
Jun 30, 2022	1.10B	-4.24M	-0.38%
Jun 30, 2021	1.10B	79.44M	7.75%
Jun 30, 2020	1.02B	195.78M	23.61%